Historically there has been a lack of diversity with respect to participation in clinical trials of new drugs. This underrepresentation can mask health and safety effects of a drug on diverse populations. The panel of speakers will address the historical lack of diversity in clinical trials as well as recommendations for promoting diversity in clinical trials, including a draft Guidance issued by the FDA in 2022.
Marta Delsignore will be moderating a NYC Bar Association hosted webinar titled “Diversity in Clinical Trials” and Elizabeth Mulkey will be a panelist.
Marta E. DelsignoreOf Counsel